Page last updated: 2024-11-12

renin inhibitory peptide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

renin inhibitory peptide: angiotensinogen analog [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16130968
MeSH IDM0089341

Synonyms (3)

Synonym
renin inhibitory peptide
l-lysine, n(2)-(n-(n-(n-(n-(n-(n-(1-(n-l-prolyl-l-histidyl)-l-prolyl)-l-phenylalanyl)-l-histidyl)-l-phenylalanyl)-l-phenylalanyl)-l-valyl)-l-tyrosyl)-
prolyl-histidyl-prolyl-phenylalanyl-histidyl-phenylalanyl-phenylalanyl-valyl-tyrosyl-lysyl

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Serum levels for U-71,038 determined 30 min after dosing averaged less than 300 ng equivalents/ml suggesting that less than 1% of the administered dose was in the systemic circulation at that time."( Development of a sensitive activity assay for high-volume evaluation of human renin inhibitory peptides in rat serum: results with U-71,038.
Cook, KJ; Cornette, JC; Evans, DB; Friis, JM; Harris, DW; Lakings, DB; Rush, BD; Ruwart, MJ; Sharma, SK; Wilkinson, KF, 1990
)
0.51
" Plasma Ang II was 83 +/- 20 fmol/ml in vehicle-treated rats and fell to 28 +/- 3 fmol/ml with ramipril (10 mg/kg), the dose-response zenith."( Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
Allan, DR; Coletti, C; Hollenberg, NK; Hui, KY, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (50.00)18.7374
1990's12 (31.58)18.2507
2000's1 (2.63)29.6817
2010's6 (15.79)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.52 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (5.13%)5.53%
Reviews5 (12.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (82.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]